Charlie Strange

Cyclophosphamide versus Placebo in Scleroderma Lung Disease

Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease

Keith C. Meyer, Ganesh Raghu, Robert P. Baughman et al. · American Journal of Respiratory and Critical Care Medicine · 2012 · 1.1K citations

Veterinary Medicine, Pathology, Cellular Pathology +16

Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis

Francis X. McCormack, Yoshikazu Inoue, Joel Moss et al. · New England Journal of Medicine · 2011 · 1.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

Donald P. Tashkin, Michael D. Roth, Philip J. Clements et al. · The Lancet Respiratory Medicine · 2016 · 1.1K citations

Medicine, Pharmacology, Pharmacotherapy +11

A Randomized Study of Endobronchial Valves for Advanced Emphysema

Frank C. Sciurba, Armin Ernst, Felix Herth et al. · New England Journal of Medicine · 2010 · 848 citations · Full text

Health Professions, Clinical Sciences, Surgery +17